Weijian Wu

755 total citations
20 papers, 562 citations indexed

About

Weijian Wu is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Weijian Wu has authored 20 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Epidemiology. Recurrent topics in Weijian Wu's work include Computational Drug Discovery Methods (3 papers), Ubiquitin and proteasome pathways (3 papers) and interferon and immune responses (2 papers). Weijian Wu is often cited by papers focused on Computational Drug Discovery Methods (3 papers), Ubiquitin and proteasome pathways (3 papers) and interferon and immune responses (2 papers). Weijian Wu collaborates with scholars based in China, United States and Singapore. Weijian Wu's co-authors include Dayong Yang, Chi Yao, Han Tang, Jianpu Tang, Dan Luo, Weiwei Guo, Hua Zou, Longqiang Luo, Wen Zhang and Wenyi Xiao and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Weijian Wu

18 papers receiving 559 citations

Peers

Countries citing papers authored by Weijian Wu

Since Specialization

Citations

This map shows the geographic impact of Weijian Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijian Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijian Wu more than expected).

Fields of papers citing papers by Weijian Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijian Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijian Wu. The network helps show where Weijian Wu may publish in the future.

Co-authorship network of co-authors of Weijian Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Weijian Wu. A scholar is included among the top collaborators of Weijian Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijian Wu. Weijian Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Surface modified slag fiber reinforced asphalt mixture: Enhancement of pavement performance and field validation 2025 ·Case Studies in Construction Materials ·Mingen Fei, (unknown), Weijian Wu, Xiaoqian Yan, (unknown), (unknown), Haiming Yu, Shuyi Wu, Xiaoyan Zheng, Wendi Liu, Renhui Qiu	2
2	Targeting USP1 Potentiates Radiation‐Induced Type I IFN‐Dependent Antitumor Immunity by Enhancing Oligo‐Ubiquitinated SAR1A‐Mediated STING Trafficking and Activation 2025 ·Advanced Science ·Weilin Zhou, Yuxuan Zhao, Wenjing Qin, Weijian Wu, (unknown), Yiqiu Zhang, (unknown), Xue Chen, (unknown), Yan Kang, (unknown), Jiaojiao Zhao, Junmin Quan, (unknown), Xianzhang Bu, Xin Yue	1
3	Targeting the TRIM14/USP14 axis enhances radiotherapy efficacy by inducing GPX4 degradation and disrupting ferroptotic defense in HCC 2025 ·Cell Death and Disease ·Xin Yue, (unknown), (unknown), (unknown), Weilin Zhou, Weijian Wu, Wenjing Qin, Yuxuan Zhao, Xianzhang Bu, Zhenwei Peng	3
4	Polymer modifier from vinyl ester and soybean oil derivatives: enhancing recycled asphalt and PET fiber reinforced asphalt mixture 2025 ·SHILAP Revista de lepidopterología ·Mingen Fei, (unknown), Haiming Yu, Weijian Wu, (unknown), Xiaoyan Zheng, Shuyi Wu, Xueqiang Liu, Wendi Liu, Renhui Qiu	0
5	Local color display technology 2024 ·Electronics Letters ·Weijian Wu	0
6	Caged Luciferase Inhibitor‐Based Bioluminescence Switching Strategy Enables Efficient Detection of Serum APN Activity and the Identification of Its Roles in Metastasis of Non‐Small Cell Lung Cancer** 2023 ·Chemistry - A European Journal ·Yunzhi Li, Jiaxin Wu, (unknown), Yiqiu Zhang, Ji‐Yu Wang, (unknown), (unknown), Xiaoyue Zhang, Tingyu Liu, Deyuan Zhou, Yukun Kuang, Weijian Wu, (unknown), Zunfu Ke, Xianzhang Bu, Xin Yue	1
7	NONO regulates multiple cytokine production in sepsis via the ERK1/2 signaling pathway 2022 ·Molecular Immunology ·Ya Niu, Guangyu Xu, Shaoping Zhu, (unknown), Changli Wu, (unknown), Chunling Chen, (unknown), Haihua Luo, Simin Deng, Weijian Wu, (unknown), Ming Liu, Yong Jiang, Xiujuan Zhang	4
8	Blockade of USP14 potentiates type I interferon signaling and radiation-induced antitumor immunity via preventing IRF3 deubiquitination 2022 ·Cellular Oncology ·Weijian Wu, Huiying Xu, (unknown), (unknown), (unknown), Jiaxin Wu, (unknown), Yunzhi Li, (unknown), Yuxuan Zhao, Junmin Quan, Xin Yue, Xianzhang Bu	4
9	Stabilization of DEPTOR sensitizes hypopharyngeal cancer to radiotherapy via targeting degradation 2022 ·Molecular Therapy — Oncolytics ·(unknown), (unknown), Xin Yue, Tingyu Liu, (unknown), Dongmei Jiang, Weijian Wu, (unknown), Yan Wang, (unknown), Ziyang Wang, (unknown), Meiyan Zhu, Shasha He, Xiaoyue Zhang, Xianzhang Bu, Ranyi Liu, Zhenwei Peng, Yong Chen	4
10	Identification of 2-Benzylidene-tetralone Derivatives as Highly Potent and Reversible Firefly Luciferase Inhibitors 2022 ·ACS Medicinal Chemistry Letters ·Yunzhi Li, (unknown), Huiying Xu, Weijian Wu, (unknown), Jiaxin Wu, Tingyu Liu, Guohui Wan, Xin Yue, Xianzhang Bu	2
11	Self-assembly of stem cell membrane-camouflaged nanocomplex for microRNA-mediated repair of myocardial infarction injury 2020 ·Biomaterials ·Chi Yao, Weijian Wu, Han Tang, Xuemei Jia, Jianpu Tang, Xinhua Ruan, Feng Li, David Tai Leong, Dan Luo, Dayong Yang	79
12	Glioblastoma precision therapy: From the bench to the clinic 2020 ·Cancer Letters ·Zhou Yuan, Weijian Wu, (unknown), Dayong Yang, Chunzhi Zhang	28
13	[Trend of Syphilis Infection among Voluntary Blood Donors in Foshan City from 2008 to 2017]. 2020 ·PubMed ·(unknown), Weijian Wu, (unknown), Yu‐Ting Yu, Yanhua Li, (unknown)	2
14	Double Rolling Circle Amplification Generates Physically Cross-Linked DNA Network for Stem Cell Fishing 2020 ·Journal of the American Chemical Society ·Chi Yao, Han Tang, Weijian Wu, Jianpu Tang, Weiwei Guo, Dan Luo, Dayong Yang	194
15	Design and Discovery of Natural Cyclopeptide Skeleton Based Programmed Death Ligand 1 Inhibitor as Immune Modulator for Cancer Therapy 2020 ·Journal of Medicinal Chemistry ·(unknown), Daoyuan Chen, (unknown), Weijian Wu, Huiying Xu, (unknown), Hui Su, (unknown), Weiyan Shao, Arabella Wan, Binhua P. Zhou, Guohui Wan, Xianzhang Bu	13
16	Precise modelling and interpretation of bioactivities of ligands targeting G protein-coupled receptors 2019 ·Bioinformatics ·Jiansheng Wu, Ben Liu, Wallace Chan, Weijian Wu, Tao Pang, Haifeng Hu, Shancheng Yan, Xiaoyan Ke, Yang Zhang	13
17	WDL-RF: predicting bioactivities of ligand molecules acting with G protein-coupled receptors by combining weighted deep learning and random forest 2018 ·Bioinformatics ·Jiansheng Wu, Qiuming Zhang, Weijian Wu, Tao Pang, Haifeng Hu, Wallace Chan, Xiaoyan Ke, Yang Zhang	37
18	Accurate Prediction of Immunogenic T-Cell Epitopes from Epitope Sequences Using the Genetic Algorithm-Based Ensemble Learning 2015 ·PLoS ONE ·Wen Zhang, Yanqing Niu, Hua Zou, Longqiang Luo, (unknown), Weijian Wu	32
19	Predicting potential side effects of drugs by recommender methods and ensemble learning 2015 ·Neurocomputing ·Wen Zhang, Hua Zou, Longqiang Luo, (unknown), Weijian Wu, Wenyi Xiao	125
20	Advanced electrochemical performance of Li1.95Al0.05Na2Ti6O14 anode material for lithium ion batteries 2015 ·Electrochimica Acta ·Mengmeng Lao, Peng Li, Pengfei Wang, Xi Zheng, Weijian Wu, Miao Shui, Xiaoting Lin, Nengbing Long, Jie Shu	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact